Sustained spontaneous remission in KMT2A-MLLT3 mutated myeloid sarcoma

Ann Hematol. 2023 May;102(5):1271-1274. doi: 10.1007/s00277-023-05173-x. Epub 2023 Mar 17.

Authors

Chris Armstrong¹, Wing-Yan Au², Edmond S K Ma³, Simon Ho Man Wong⁴, Nina Orfali⁵

Affiliations

¹ Department of Haematology, St. James' Hospital, Dublin, Ireland. [email protected].
² Blood-med Clinic, Hong Kong, Hong Kong.
³ Department of Pathology, Hong Kong Sanatorium & Hospital, Hong Kong, Hong Kong.
⁴ Medhealth Diagnostic MRI & PET-CT Centre, Hong Kong, Hong Kong.
⁵ Department of Haematology, St. James' Hospital, Dublin, Ireland.

PMID: 36930260
DOI: 10.1007/s00277-023-05173-x

No abstract available

Publication types

Letter

MeSH terms

Humans
Leukemia, Myeloid, Acute* / genetics
Myeloid-Lymphoid Leukemia Protein / genetics
Nuclear Proteins
Remission, Spontaneous
Sarcoma, Myeloid* / genetics

Substances

MLLT3 protein, human
Myeloid-Lymphoid Leukemia Protein
Nuclear Proteins
KMT2A protein, human